Inspire Medical Systems (INSP) director receives 3,562 RSUs in equity grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

mcCormick Shawn reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems director Shawn McCormick reported a new equity grant. He received 3,562 shares of common stock in the form of Restricted Stock Units at no cash cost, increasing his directly held stake to 28,408 shares.

The RSUs vest on the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, as long as he continues serving the company. The filing also shows 3,000 shares held indirectly through a trust.

Insider Trade Summary 10b5-1

2 transactions reported

Mixed 2 txns

Insider mcCormick Shawn

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,562	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 28,408 shares (Direct, null); Common Stock — 3,000 shares (Indirect, By trust)

Footnotes (1)

[object Object]

Key Figures

RSU award size: 3,562 shares Grant price: $0.0000 per share Direct holdings after grant: 28,408 shares +1 more

4 metrics

RSU award size 3,562 shares Restricted Stock Units granted to director Shawn McCormick

Grant price $0.0000 per share RSUs granted at no cash cost

Direct holdings after grant 28,408 shares Common stock directly owned following RSU award

Indirect holdings 3,000 shares Common stock held indirectly by trust

Key Terms

Restricted Stock Units ("RSUs"), Change of Control, 2018 Incentive Award Plan

3 terms

Restricted Stock Units ("RSUs") financial

"Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Change of Control financial

"the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan)"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

2018 Incentive Award Plan financial

"Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service"

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 06:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

mcCormick Shawn

(Last)

(First)

(Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY

MINNESOTA

55416

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		3,562⁽¹⁾	A	$0	28,408	D
Common Stock								3,000	I	By trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

	/s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Inspire Medical Systems (INSP) director Shawn McCormick report on this Form 4?

Shawn McCormick reported receiving 3,562 Restricted Stock Units of Inspire Medical Systems common stock as an equity award. The grant increased his directly held position to 28,408 shares, with an additional 3,000 shares reported as indirectly owned through a trust.

How many Inspire Medical Systems (INSP) shares did Shawn McCormick acquire in this grant?

He acquired 3,562 shares in the form of Restricted Stock Units, each representing one share of common stock. These RSUs were granted at no cash purchase price and are subject to future vesting conditions tied to time and potential Change of Control events.

What are the vesting terms of Shawn McCormick’s new RSUs in INSP?

The 3,562 Restricted Stock Units vest on the earlier of one year after the grant date or immediately before a Change of Control under the 2018 Incentive Award Plan. Vesting requires Shawn McCormick’s continued service with Inspire Medical Systems through the applicable vesting date.

What are Shawn McCormick’s total reported Inspire Medical Systems (INSP) holdings after this transaction?

After the RSU award, Shawn McCormick directly holds 28,408 shares of Inspire Medical Systems common stock. The Form 4 also reports 3,000 additional shares as indirectly owned through a trust, providing visibility into both his direct and indirect equity exposure.

Is Shawn McCormick’s RSU grant in INSP an open-market purchase or compensation award?

The filing shows a compensation-related equity award, not an open-market purchase. Transaction code “A” and a zero dollar price indicate 3,562 shares were granted as Restricted Stock Units under the 2018 Incentive Award Plan, subject to standard vesting conditions.